01dragonslayer
Regular
We all know have heard the Bro-Science that HGH is good for fat loss…but is it really? Much of Bro-Science is quite true, gained from the crucible of human trials by the body builders themselves. But much of Bro-Science is bunk. So what does science have to say about HGH and fat loss? Well read on, my brothers and sisters, and you will see! Not only does it help with fat loss, it also reduces your bad cholesterol (and increases collagen growth). I will break each study up into snippets and discuss the pieces individually.
The first fat reduction study is: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. It can be found here: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure - PubMed
Quote Quote
Thirty men, 48-66 yr old, with abdominal/visceral obesity were treated with recombinant human GH (rhGH) in a 9-month randomized, double-blind, placebo-controlled trial. The daily dose of rhGH was 9.5 micrograms/kg.
1mg is 2.7IUs of HGH. A 200 pound person is about 90kg (yeah, 91, but 90 makes the math easier). 9.5 is basically 10, which makes for very easy math. 90 X 10 = 900. 900 micrograms is 0.9 milligrams. 0.9 X 2.7 = 2.43 IUs. That is in the range that most people use, since most people will use from 2IUs to 4IUs per day.
Quote Quote
In response to the rhGH treatment, total body fat and abdominal sc and visceral adipose tissue decreased by 9.2 +/- 2.4%, 6.1 +/- 3.2%, and 18.1 +/- 7.6%, respectively. After an initial decrease in the glucose disposal rate (GDR) at 6 weeks, the GDR increased in the rhGH-treated group as compared with the placebo-treated one (P < 0.05). The mean serum concentrations of total cholesterol (P < 0.01) and triglyceride (P < 0.05) decreased, whereas blood glucose and serum insulin concentrations were unaffected by the rhGH treatment. Furthermore, diastolic blood pressure decreased and systolic blood pressure was unchanged in response to rhGH treatment. This trial has demonstrated that GH can favorably affect some of the multiple perturbations associated with abdominal/visceral obesity. This includes a reduction in abdominal/visceral obesity, an improved insulin sensitivity, and favorable effects on lipoprotein metabolism and diastolic blood pressure.
The average fat loss after 9 months of about 2.5IUs of HGH was 9.2%, with some losing as much at 18%!! Overall health was improved as well. The only negative effect was the 2 hour glucose level (GDR). It was harder for the body to remove glucose immediately after its induction, so keep that in mind. After that 2 hour period, the glucose levels were better for those using HGH than those not using it.
And not to leave out the post-menopausal women and fat reduction, here is another study: Growth Hormone Treatment Reduces Abdominal Visceral Fat in Postmenopausal Women with Abdominal Obesity: A 12-Month Placebo-Controlled Trial Found here: http://press.endocrine.org/doi/full/....WtSPw6w1.dpuf
Quote Quote
Abdominal obesity is associated with blunted GH secretion and a cluster of cardiovascular risk factors that characterize the metabolic syndrome. GH treatment in abdominally obese men reduces visceral adipose tissue and has beneficial effects on the metabolic profile. There are no long-term data on the effects of GH treatment on postmenopausal women with abdominal obesity. Forty postmenopausal women with abdominal obesity participated in a randomized, double-blind, placebo-controlled, 12-month trial with GH (0.67 mg/d). The primary aim was to study the effect of GH treatment on insulin sensitivity.
Forty women with a mean age of 57.3 yr (range, 51–63 yr) were studied. The initial dose of GH was 0.13 mg/d (0.4 IU/d), which was then increased to 0.27 mg/d (0.8 IU/d) after 2 wk, 0.4 mg/d (1.2 IU/d) after 4 wk, 0.53 mg/d (1.6 IU/d) after 5 wk and, after 6 wk, to the target dose of 0.67 mg/d (2.0 IU/d).
The target dose was 2IU a day. A nice low number that most users will be at or above.
Quote Quote
A reduction in serum total cholesterol and LDL cholesterol was observed in the GH-treated women, although the reduction in LDL cholesterol was more marked after the first 6 months (10%) compared with 12 months (5%). In some studies dealing with GH-deficient patients receiving GH replacement therapy, a transient reduction in total cholesterol, LDL cholesterol, and the total cholesterol/HDL ratio and an increase in Lp (a) have been reported (36, 37). In contrast to these data, no significant changes in Lp (a) or total apoB were observed in our study. One plausible explanation is that the target dose of GH in our study was considerably lower than that used in these previous trials and that men may respond more markedly/differently than women in terms of the lipoprotein metabolism (38). Assessments of body composition by CT scan showed a clear reduction in VAT and an increased amount of thigh muscle mass in the GH-treated women. In contrast to a similar study involving middle-aged men with abdominal obesity who received GH treatment for 9 months (17), we did not find any changes in abdominal or thigh sc AT, suggesting that postmenopausal women are less responsive to the lipolytic effect of GH in the sc fat depots.
HGH is great for reducing cholesteral in women. VAT is visceral adipose tissue, which is the inner belly fat (as opposed to the belly fat found just under the skin). It seems that women will lose the fat on the upper thigh, but not the inner belly fat. Men lose the inner belly fat (and tend to not store fat on the upper thighs anyway, so hard to lose fat that is not there). Sorry ladies, no or very little spot reduction in the belly for you at 2IUs, though you WILL lose fat on the upper thighs. The study does say the results might be different at 4IUs, but they did not test at that level.
The lack of belly fat loss in women was also proven in another study: Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls found here: http://www.ncbi.nlm.nih.gov/pmc/arti...rticle_359.pdf
It mirrors the first female study, just on a younger group of women (under 18 years but past puberty). So again, sorry ladies, no belly fat reduction for you. HGH for fat loss and reduced cholesterol. Still, it does improve many other things (cholesteral, the look and feel of skin and nails, and a better overall feeling of well being) so do not discount using HGH.
HGH is good for reducing cholesterol.
HGH is good for belly fat loss in men.
HGH is good for upper thigh fat loss in women, but will NOT reduce belly fat in women.
The first fat reduction study is: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. It can be found here: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure - PubMed
Quote Quote
Thirty men, 48-66 yr old, with abdominal/visceral obesity were treated with recombinant human GH (rhGH) in a 9-month randomized, double-blind, placebo-controlled trial. The daily dose of rhGH was 9.5 micrograms/kg.
1mg is 2.7IUs of HGH. A 200 pound person is about 90kg (yeah, 91, but 90 makes the math easier). 9.5 is basically 10, which makes for very easy math. 90 X 10 = 900. 900 micrograms is 0.9 milligrams. 0.9 X 2.7 = 2.43 IUs. That is in the range that most people use, since most people will use from 2IUs to 4IUs per day.
Quote Quote
In response to the rhGH treatment, total body fat and abdominal sc and visceral adipose tissue decreased by 9.2 +/- 2.4%, 6.1 +/- 3.2%, and 18.1 +/- 7.6%, respectively. After an initial decrease in the glucose disposal rate (GDR) at 6 weeks, the GDR increased in the rhGH-treated group as compared with the placebo-treated one (P < 0.05). The mean serum concentrations of total cholesterol (P < 0.01) and triglyceride (P < 0.05) decreased, whereas blood glucose and serum insulin concentrations were unaffected by the rhGH treatment. Furthermore, diastolic blood pressure decreased and systolic blood pressure was unchanged in response to rhGH treatment. This trial has demonstrated that GH can favorably affect some of the multiple perturbations associated with abdominal/visceral obesity. This includes a reduction in abdominal/visceral obesity, an improved insulin sensitivity, and favorable effects on lipoprotein metabolism and diastolic blood pressure.
The average fat loss after 9 months of about 2.5IUs of HGH was 9.2%, with some losing as much at 18%!! Overall health was improved as well. The only negative effect was the 2 hour glucose level (GDR). It was harder for the body to remove glucose immediately after its induction, so keep that in mind. After that 2 hour period, the glucose levels were better for those using HGH than those not using it.
And not to leave out the post-menopausal women and fat reduction, here is another study: Growth Hormone Treatment Reduces Abdominal Visceral Fat in Postmenopausal Women with Abdominal Obesity: A 12-Month Placebo-Controlled Trial Found here: http://press.endocrine.org/doi/full/....WtSPw6w1.dpuf
Quote Quote
Abdominal obesity is associated with blunted GH secretion and a cluster of cardiovascular risk factors that characterize the metabolic syndrome. GH treatment in abdominally obese men reduces visceral adipose tissue and has beneficial effects on the metabolic profile. There are no long-term data on the effects of GH treatment on postmenopausal women with abdominal obesity. Forty postmenopausal women with abdominal obesity participated in a randomized, double-blind, placebo-controlled, 12-month trial with GH (0.67 mg/d). The primary aim was to study the effect of GH treatment on insulin sensitivity.
Forty women with a mean age of 57.3 yr (range, 51–63 yr) were studied. The initial dose of GH was 0.13 mg/d (0.4 IU/d), which was then increased to 0.27 mg/d (0.8 IU/d) after 2 wk, 0.4 mg/d (1.2 IU/d) after 4 wk, 0.53 mg/d (1.6 IU/d) after 5 wk and, after 6 wk, to the target dose of 0.67 mg/d (2.0 IU/d).
The target dose was 2IU a day. A nice low number that most users will be at or above.
Quote Quote
A reduction in serum total cholesterol and LDL cholesterol was observed in the GH-treated women, although the reduction in LDL cholesterol was more marked after the first 6 months (10%) compared with 12 months (5%). In some studies dealing with GH-deficient patients receiving GH replacement therapy, a transient reduction in total cholesterol, LDL cholesterol, and the total cholesterol/HDL ratio and an increase in Lp (a) have been reported (36, 37). In contrast to these data, no significant changes in Lp (a) or total apoB were observed in our study. One plausible explanation is that the target dose of GH in our study was considerably lower than that used in these previous trials and that men may respond more markedly/differently than women in terms of the lipoprotein metabolism (38). Assessments of body composition by CT scan showed a clear reduction in VAT and an increased amount of thigh muscle mass in the GH-treated women. In contrast to a similar study involving middle-aged men with abdominal obesity who received GH treatment for 9 months (17), we did not find any changes in abdominal or thigh sc AT, suggesting that postmenopausal women are less responsive to the lipolytic effect of GH in the sc fat depots.
HGH is great for reducing cholesteral in women. VAT is visceral adipose tissue, which is the inner belly fat (as opposed to the belly fat found just under the skin). It seems that women will lose the fat on the upper thigh, but not the inner belly fat. Men lose the inner belly fat (and tend to not store fat on the upper thighs anyway, so hard to lose fat that is not there). Sorry ladies, no or very little spot reduction in the belly for you at 2IUs, though you WILL lose fat on the upper thighs. The study does say the results might be different at 4IUs, but they did not test at that level.
The lack of belly fat loss in women was also proven in another study: Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls found here: http://www.ncbi.nlm.nih.gov/pmc/arti...rticle_359.pdf
It mirrors the first female study, just on a younger group of women (under 18 years but past puberty). So again, sorry ladies, no belly fat reduction for you. HGH for fat loss and reduced cholesterol. Still, it does improve many other things (cholesteral, the look and feel of skin and nails, and a better overall feeling of well being) so do not discount using HGH.
- Updated - - -
HGH is good for reducing cholesterol.
HGH is good for belly fat loss in men.
HGH is good for upper thigh fat loss in women, but will NOT reduce belly fat in women.
